1. Japan Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Ship Healthcare Holdings, Inc.

Ship Healthcare Holdings, Inc.

14.00
EUR
+0.10
(+0.72%)
Nov 10Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
3,210.76
3,080.85
3,105.48
4,043.84
4,205.27
4,500.27
5,089.51
5,262.55
5,451.52
6,065.54
6,687.86
7,188.43
7,731.22
- -
Basic EPS, GAAP
105.58
84.22
89.54
93.15
102.27
113.87
124.01
129.99
129.01
127.85
146.26
160.34
144.19
- -
Free Cash Flow per Basic Share
121.19
-59.31
92.17
92.97
141.49
76.16
212.22
156.26
94.94
108.08
297.76
171.72
186.92
- -
Dividend per Share
23
21.74
27.5
26.9
29.99
32.82
35.03
37.64
40
41
41.99
49.99
58.91
- -
Book Value per Share
586.64
762.14
819.68
903.01
986.95
1,001.68
1,073.35
2,362.26
1,253.72
1,357.04
1,478.82
1,580.03
1,641.73
- -
Tangible Book Value per Share
448.84
648.56
695.18
782.38
870.55
893.2
972.96
2,137.97
1,154.58
1,185.88
1,321.37
1,445.1
1,514.36
- -
Basic Weighted Avg Shares
81
89
99
101
101
99
95
94
94
94
94
94
93
93
Sales/Revenue/Turnover
259,189
273,327
306,853
408,487
425,566
444,048
484,395
497,156
514,353
572,285
630,988
678,229
718,163
- -
Operating Margin (%)
5.35
4.98
4.58
3.93
4.29
4.04
3.88
4.39
3.99
3.7
3.89
3.65
3.39
- -
Depreciation Expense
3,416
3,847
4,496
4,669
4,185
4,503
4,853
5,127
5,488
7,450
7,435
7,369
7,241
- -
Net Income, GAAP
8,523
7,472
8,847
9,410
10,350
11,236
11,803
12,280
12,172
12,063
13,799
15,128
13,394
- -
Effective Tax Rate (%)
41.15
44.88
34.52
40.65
39.76
40.06
40.47
41.78
40.46
43.85
37.12
38.45
41.53
- -
Profit Margin (%)
3.29
2.73
2.88
2.3
2.43
2.53
2.44
2.47
2.37
2.11
2.19
2.23
1.87
- -
Working Capital
15,075
46,891
41,032
48,053
53,523
73,395
77,384
69,948
78,158
60,221
78,858
71,444
74,685
- -
LT Debt
22,895
31,629
31,218
36,146
36,765
64,816
62,078
57,787
55,011
41,571
50,459
30,620
25,606
- -
Total Equity
47,619
75,862
81,521
93,630
102,352
97,734
104,681
115,103
122,317
131,114
142,226
150,279
152,427
- -
Return on Invested Capital (%)
10.09
7.45
7.74
7.27
7.53
6.64
6.41
6.99
6.52
5.95
7.43
7.66
7.49
- -
Return on Capital (%)
11.24
7.81
7.72
7.42
7.32
7.32
7.01
7.03
6.67
6.57
6.98
8.04
7.3
- -
Return on Common Equity (%)
19.08
12.2
11.32
10.92
10.82
11.51
11.97
11.52
10.6
9.79
10.31
10.48
8.92
- -

Capital Structure

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
ST Debt
866
4,762
- -
LT Borrowings
29,411
25,606
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
92
92
92
Market Capitalization
- -
- -
- -

Working Capital

JPY

•

in mil. unless spec.
Sep'26
Mar'26
Jun'27
Total Current Assets
237,846
270,599
- -
Cash, Cash Equivalents & STI
75,325
80,566
- -
Accounts Receivable, Net
113,214
137,754
- -
Inventories
32,807
30,457
- -
Total Current Liabilities
171,403
195,914
- -
Payables & Accruals
- -
- -
- -
ST Debt
866
4,762
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.58%
5.81%
1.43%
Free Cash Flow
26.48%
22.97%
7.17%
Net Income, GAAP
4.48%
2.16%
-11.46%
Sales/Revenue/Turnover
9.17%
7.67%
5.89%
Total Cash Common Dividend
- -
9.22%
16.01%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
678,229
2026
- -
- -
- -
- -
718,163
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
160.34
2026
- -
- -
- -
- -
144.19
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
49.99
2026
- -
- -
- -
- -
58.91
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Futoshi Ohashi
Full Time Employees
7,819
Sector
Distribution services
Industry
Medical distributors
Address
3-20-8 Kasuga Suita Japan 565-0853
IPO Date
Feb 22, 2005
Website
shiphd.co.jp
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Ship Healthcare Holdings, Inc. (3360.T) operates as a diversified healthcare provider primarily in Japan, delivering one-stop solutions to medical institutions through five core business segments: Total Pack Produce, which offers comprehensive planning, construction, relocation, expansion, and renovation services for regional core hospitals and university hospitals including medical gas piping equipment, operating room interiors, shadowless surgical lights, rehabilitation equipment, and special bathtubs; Medical Supply, which sells diagnostic materials, medical consumables, and specified insurance medical supplies while providing supply processing and distribution services across approximately 100,000 beds in 272 facilities; Lifecare, which manages around 70 nursing care facilities nationwide ranging from large-scale over 300 beds to small multifunctional units in partnership with medical institutions; Food Provision, which supplies healthcare food services to large medical sites, welfare, and nursing care facilities; and Dispensing Pharmacy, which runs over 130 pharmacies including in-hospital, gate, and home-delivery operations serving as community cornerstones. Founded in August 1992 and headquartered at 3-20-8 Kasuga, Suita, Osaka, the company employs 7,805 consolidated permanent staff and generated JPY678.2 billion in net sales for the fiscal year ended March 31, 2025. Recent strategic changes include the consolidation of its five group dispensing pharmacy subsidiaries into a single entity in April 2025 to enhance operational efficiency; integration of five group companies in the Medical Supply segment in October 2024 supporting new SPD facility launches; launch of the "SHIP VISION 2030" medium-term management plan in May 2025 evolving its mission to "Creating environments for better living" with portfolio optimization, internal reorganizations, logistics reforms, and growth targets of JPY700 billion in net sales for FY03/2026; ongoing share buybacks up to JPY5 billion through December 2025 including a tranche of 1,955,400 shares from July to September 2025; and small-scale M&As alongside new pharmacy store openings in the Dispensing Pharmacy business.